Case number 1:22-cv-00155
Acerta Pharma B.V. et al v. Natco Pharma Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 13, 2022 | 29 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Natco Pharma Inc. & Natco Pharma LTD.s Initial Disclosures filed by Natco Pharma Limited, Natco Pharma, Inc..(Green, James) |
| Jun 27, 2022 | 28 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to paragraph 4(a) of the Delaware Default Standard for Discovery filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V..(Silver, Daniel) |
| Jun 22, 2022 | 27 | Certification for Jihad Komis (1) |
| Jun 22, 2022 | 27 | Main Document (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jihad Komis - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Attachments: # (1) Certification for Jihad Komis)(Joyce, Alexandra) |
| Jun 22, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (27 in 22-cv-155-RGA; 28 in 22-cv-163-RGA; 36 in 22-cv-154-RGA; 32 in 22-cv-164-RGA; 32 in 22-cv-162-RGA) MOTION for Pro Hac Vice Appearance of Attorney Jihad Komis, filed by Merck Sharp & Dohme B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca AB, Acerta Pharma B.V.. Signed by Judge Richard G. Andrews on 6/22/2022. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(nms) |
| May 13, 2022 | 26 | Scheduling Order (13) Docket Text: SCHEDULING ORDER: Joinder of Parties due by 1/9/2023. Amended Pleadings due by 1/9/2023. Fact Discovery completed by 2/12/2024. Joint Claim Construction Brief due by 7/31/2023. A Markman Hearing is set for 8/31/2023, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 2/21/2025, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial on invalidity is set to start 3/3/2025, at 8:30 AM in Courtroom 6A. One day Bench Trials on infringement is set to start 3/10/2025, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 5/13/2022. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(nms) |
| May 13, 2022 | 25 | Proposed Order (15) Docket Text: PROPOSED Scheduling Order, by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) Modified on 5/13/2022 (nms). |
| May 11, 2022 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Rule 16(b) Telephone Scheduling Conference held on 5/11/2022. Counsel for Plaintiffs: A. Joyce. Counsel for Defendants: D. Gattuso, M. Haney, M. Goeller. A 3-day Bench Trial on Invalidity is scheduled to begin on 3/3/2025. A Pretrial Conference is set for 2/21/2025, at 9:00 AM. Plaintiff's are directed to resubmit the proposed scheduling order reflecting the rulings the Court made during the hearing. (Court Reporter Heather Triozzi.) Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(lak) |
| May 10, 2022 | 24 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Alexander S. Zolan - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) |
| May 10, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Alexander S. Zolan for Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, and Merck Sharp & Dohme B.V. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| May 10, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 24 in 22-cv-155-RGA; D.I. 28 in 22-cv-154-RGA; D.I. 29 in 22-cv-164-RGA; D.I. 29 in 22-cv-162-RGA; D.I. 24 in 22-cv-163-RGA) MOTION for Pro Hac Vice Appearance of Attorney Alexander S. Zolan, filed by Merck Sharp & Dohme B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca AB, Acerta Pharma B.V.. Signed by Judge Richard G. Andrews on 5/10/2022. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(nms) |
| May 9, 2022 | 23 | Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews from Alexandra M. Joyce, Esq. regarding Dial-In for Rule 16 Teleconference. (Joyce, Alexandra) |
| May 9, 2022 | 22 | Proposed Order (16) Docket Text: PROPOSED Scheduling Order, by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) Modified on 5/10/2022 (nms). |
| May 6, 2022 | 21 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Natco Pharma Inc. & Natco Pharma LTD. Requests for Production to Plaintiffs Nos. (1-4) filed by Natco Pharma Limited, Natco Pharma, Inc..(Green, James) |
| Apr 29, 2022 | 20 | Notice of Change of Address (2) Docket Text: NOTICE of Change of Address by Alexandra M. Joyce (Joyce, Alexandra) |
| Apr 13, 2022 | 19 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 5/11/2022, at 3:00 PM before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 4/13/2022. (nms) |
| Apr 12, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Hayley M. Ostrin, Karen L. Beckman, Andrew O. Larsen, and Christopher J. Sorenson for Natco Pharma Limited and Natco Pharma, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Apr 11, 2022 | 13 | Certificate of Service (1) |
| Apr 11, 2022 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pro hac motions filed at D.I. 15 through D.I. 16 have been removed from the docket as they were incompletely formatted. The certifications lacked counsels' firm address information for future service. Defendants are to refile the motions and include this information. (nms) |
| Apr 11, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [16] MOTION for Pro Hac Vice Appearance of Attorney Andrew Larsen, filed by Natco Pharma, Inc., Natco Pharma Limited, [17] MOTION for Pro Hac Vice Appearance of Attorney Hayley Ostrin, filed by Natco Pharma, Inc., Natco Pharma Limited, [15] MOTION for Pro Hac Vice Appearance of Attorney Karen Beckman, filed by Natco Pharma, Inc., Natco Pharma Limited, [18] MOTION for Pro Hac Vice Appearance of Attorney Christopher Sorenson, filed by Natco Pharma, Inc., Natco Pharma Limited. Signed by Judge Richard G. Andrews on 4/11/2022. (nms) |
| Apr 11, 2022 | 13 | Main Document (42) Docket Text: ANSWER to [1] Complaint, by Natco Pharma Limited, Natco Pharma, Inc.. (Attachments: # (1) Certificate of Service)(Green, James) Modified on 4/11/2022 (nms). |
| Apr 11, 2022 | 14 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Natco Pharma Limited, Natco Pharma, Inc.. (Green, James) |
| Apr 11, 2022 | 15 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Karen Beckman - filed by Natco Pharma Limited, Natco Pharma, Inc.. (Green, James) |
| Apr 11, 2022 | 16 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Andrew Larsen - filed by Natco Pharma Limited, Natco Pharma, Inc.. (Green, James) |
| Apr 11, 2022 | 17 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Hayley Ostrin - filed by Natco Pharma Limited, Natco Pharma, Inc.. (Green, James) |
| Apr 11, 2022 | 18 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Christopher Sorenson - filed by Natco Pharma Limited, Natco Pharma, Inc.. (Green, James) |
| Mar 2, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kevin Hoagland-Hanson, Min Kyung Jeon, Stanley E. Fisher, David I. Berl, and Sarahi Uribe for Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V., added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(smg) |
| Feb 23, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [12] STIPULATION and Proposed Order for Extension of to Response to the Complaint (*Reset Answer Deadlines: Natco Pharma Limited answer due 4/11/2022; Natco Pharma, Inc. answer due 4/11/2022). Signed by Judge Richard G. Andrews on 2/23/2022. (nms) |
| Feb 22, 2022 | 12 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION and Proposed Order for Extension of to Response to the Complaint - filed by Natco Pharma Limited, Natco Pharma, Inc.. (Green, James) Modified on 2/23/2022 (nms). |
| Feb 17, 2022 | 11 | Certifications for David I. Berl, Stanley E. Fisher, Kevin Hoagland-Hanson, Sar (5) |
| Feb 17, 2022 | 11 | Main Document (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Stanley E. Fisher, Kevin Hoagland-Hanson, Sarahi Uribe, and Min Kyung Jeon - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Attachments: # (1) Certifications for David I. Berl, Stanley E. Fisher, Kevin Hoagland-Hanson, Sarahi Uribe, and Min Kyung Jeon)(Joyce, Alexandra) |
| Feb 17, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (12 in 22-cv-164-RGA; 11 in 22-cv-155-RGA; 11 in 22-cv-162-RGA; 11 in 22-cv-163-RGA; 11 in 22-cv-154-RGA) MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Stanley E. Fisher, Kevin Hoagland-Hanson, Sarahi Uribe, and Min Kyung Jeon, filed by Merck Sharp & Dohme B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca AB, Acerta Pharma B.V.. Signed by Judge Richard G. Andrews on 2/17/2022. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(nms) |
| Feb 9, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA (rjb) |
| Feb 7, 2022 | 10 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by AstraZeneca AB, Acerta Pharma B.V., AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. Natco Pharma, Inc. served on 2/3/2022, answer due 2/24/2022. (Joyce, Alexandra) |
| Feb 7, 2022 | 9 | Exhibit A-B (7) |
| Feb 7, 2022 | 9 | Main Document (2) Docket Text: DECLARATION of Service of Natco Pharma Limited, by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Attachments: # (1) Exhibits A-B)(Joyce, Alexandra) Modified on 2/9/2022 (nms). |
| Feb 2, 2022 | 1 | Main Document (28) Docket Text: COMPLAINT filed against Natco Pharma Limited, Natco Pharma, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3794357.) - filed by AstraZeneca AB, Acerta Pharma B.V., AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Attachments: # (1) Exhibit A-F, # (2) Civil Cover Sheet)(mal) |
| Feb 2, 2022 | 8 | Summons Issued (2) |
| Feb 2, 2022 | 8 | Main Document (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Natco Pharma Limited on 2/2/2022; Natco Pharma, Inc. on 2/2/2022. (Attachments: # (1) Summons Issued)(mal) |
| Feb 2, 2022 | 7 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP and AstraZeneca UK Limited filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP and AstraZeneca UK Limited. (mal) |
| Feb 2, 2022 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme B.V. filed by Merck Sharp & Dohme B.V.. (mal) |
| Feb 2, 2022 | 5 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,272,083. (mal) |
| Feb 2, 2022 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,290,504 ;9,758,524 ;10,239,883 ;9,796,721 ;10,167,291. (mal) |
| Feb 2, 2022 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than 12/20/2021. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: No earlier than 4/30/2025. (mal) |
| Feb 2, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Feb 2, 2022 | 1 | Civil Cover Sheet (2) |
| Feb 2, 2022 | 1 | Exhibit A-F (608) |
| Feb 2, 2022 | 1 | Complaint* (1) |
